{"id":66230,"date":"2019-12-30T23:55:42","date_gmt":"2019-12-31T04:55:42","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/fda-innvilget-gjennombruddsstatus\/"},"modified":"2019-12-30T23:55:42","modified_gmt":"2019-12-31T04:55:42","slug":"fda-innvilget-gjennombruddsstatus","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/no\/fda-innvilget-gjennombruddsstatus\/","title":{"rendered":"FDA innvilget gjennombruddsstatus"},"content":{"rendered":"<p>US Food and Drug Administration har innvilget en Breakthrough Therapy Designation til cobimetinib til behandling av pasienter med histiocyt\u00e6re svulster (Erdheim-Chester Rosai-Dorfman sykdom, Rosai-Dorfman, Langerhans histiocytose), som ikke b\u00e6rer <em>BRAF<\/em> V600-mutasjonen. Dette er ikke bare et stort fremskritt for <em>BRAF-negative<\/em> ECD pasienter, men for alle histiocytosepasienter. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>US Food and Drug Administration har innvilget en Breakthrough Therapy Designation til cobimetinib til behandling av pasienter med histiocyt\u00e6re svulster (Erdheim-Chester Rosai-Dorfman sykdom, Rosai-Dorfman, Langerhans histiocytose), som ikke b\u00e6rer BRAF [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":91089,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_wds_title":"","_wds_metadesc":"","_wds_focus-keywords":"","_wds_meta-robots-adv":"","_wds_meta-robots-noindex":false,"_wds_meta-robots-nofollow":false,"_wds_meta-robots-index":false,"_wds_meta-robots-follow":false,"_wds_autolinks-exclude":false,"_wds_canonical":"","_wds_redirect":"","_wds_opengraph":[],"_wds_twitter":[],"cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2075],"tags":[2121],"class_list":["post-66230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pressemeldinger","tag-2019-no"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/posts\/66230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/comments?post=66230"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/posts\/66230\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/media\/91089"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/media?parent=66230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/categories?post=66230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/no\/wp-json\/wp\/v2\/tags?post=66230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}